These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2543710)

  • 1. Susceptibility to AZT of HIV-1 variants grown in Epstein-Barr virus-transformed B cell lines.
    Tremblay M; Wainberg MA
    J Infect Dis; 1989 Jul; 160(1):31-6. PubMed ID: 2543710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of HIV-1 replication and antigen expression in EBV-transformed B cell lines.
    Tremblay M; Fitz-Gibbon L; Wainberg MA
    Leukemia; 1988 Dec; 2(12 Suppl):233S-240S. PubMed ID: 2849000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by AZT of HIV-1 replication in acutely infected U-937 cells.
    Boulerice F; Wainberg MA
    J Leukoc Biol; 1990 Jun; 47(6):498-505. PubMed ID: 2191063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
    Rooke R; Tremblay M; Wainberg MA
    Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV-1 activity of 3'-azido-3'-deoxythymidine (AZT) in primary mononuclear phagocytes.
    Beenhouwer DO; Rankin JA; Mellors JW
    Antiviral Res; 1992 Jul; 19(1):43-54. PubMed ID: 1444321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine.
    Lin JC; Zhang ZX; Chou TC; Sim I; Pagano JS
    J Infect Dis; 1989 Feb; 159(2):248-54. PubMed ID: 2536780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.
    Lin JC; Zhang ZX; Smith MC; Biron K; Pagano JS
    Antimicrob Agents Chemother; 1988 Feb; 32(2):265-7. PubMed ID: 2834997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pro-drug of zidovudine with enhanced efficacy against human immunodeficiency virus.
    Gogu SR; Aggarwal SK; Rangan SR; Agrawal KC
    Biochem Biophys Res Commun; 1989 Apr; 160(2):656-61. PubMed ID: 2719688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of EBV-carrying B cell lines to infection by HIV-1: variability of production of progeny virus and expression of viral antigens.
    Tremblay M; Wainberg MA
    Cancer Lett; 1989 Nov; 48(2):95-103. PubMed ID: 2479462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV compound assessment by two novel high capacity assays.
    Averett DR
    J Virol Methods; 1989 Mar; 23(3):263-76. PubMed ID: 2497128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.
    Geleziunas R; Arts EJ; Boulerice F; Goldman H; Wainberg MA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1305-12. PubMed ID: 8392310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.
    Parks WP; Parks ES; Fischl MA; Leuther MD; Allain JP; Nusinoff-Lehrman S; Barry DW; Makuch RW
    J Acquir Immune Defic Syndr (1988); 1988; 1(2):125-30. PubMed ID: 3145972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
    Van Kuyk R; Mosier DE
    Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine.
    Medina DJ; Tung PP; Lerner-Tung MB; Nelson CJ; Mellors JW; Strair RK
    J Virol; 1995 Mar; 69(3):1606-11. PubMed ID: 7853495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and origin of HIV type 1 DNA in persistently infected B lymphoblastoid cell lines.
    Guan M; Tudor G; Yang JY; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):751-7. PubMed ID: 9171219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of AZT sensitivity of HIV-1 isolates from patients treated with AZT].
    Saito T; Kondo M; Ito A; Nagao T; Imai M
    Kansenshogaku Zasshi; 1993 Apr; 67(4):311-4. PubMed ID: 8315299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes.
    Mercure L; Brenner BJ; Phaneuf D; Tsoukas C; Wainberg MA
    Antimicrob Agents Chemother; 1994 May; 38(5):986-90. PubMed ID: 8067781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.